Cargando…
Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma
Patients with advanced head and neck squamous cell carcinoma (HNSCC) usually show a dismal prognosis. It is this worthwhile to develop new, effective therapeutic regimens for these patients, such as molecular targeted therapy, which is promising as an alternative or combination treatment for HNSCC....
Autores principales: | Chou, Ming-Huei, Chuang, Hui-Ching, Lin, Yu-Tsai, Tsai, Ming-Hsien, Kao, Ying-Hsien, Lin, I-Chun, Huang, Tai-Lin, Fang, Fu-Min, Chien, Chih-Yen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002492/ https://www.ncbi.nlm.nih.gov/pubmed/33802643 http://dx.doi.org/10.3390/ijms22063046 |
Ejemplares similares
-
Systemic and Local Effects Among Patients With Betel Quid-Related Oral Cancer
por: Chuang, Hui-Ching, et al.
Publicado: (2022) -
Cancer and mTOR inhibitors in kidney transplantation recipients
por: Kao, Chih-Chin, et al.
Publicado: (2018) -
The Clinical Impacts of Pretreatment Peripheral Blood Ratio on Lymphocytes, Monocytes, and Neutrophils Among Patients with Laryngeal/Hypopharyngeal Cancer Treated by Chemoradiation/Radiation
por: Chuang, Hui-Ching, et al.
Publicado: (2020) -
Clinical impact of albumin in advanced head and neck cancer patients with free flap reconstruction—a retrospective study
por: Tsai, Ming-Hsien, et al.
Publicado: (2018) -
Stereotactic body radiotherapy plus cetuximab for previously irradiated un-resectable head and neck cancer
por: Huang, Tai-Lin, et al.
Publicado: (2022)